RPE65 Gene: Retinoid Isomerase in Visual Cycle and Inherited Retinal Dystrophy

Comprehensive biomedical reference for RPE65: genomic context, protein function, disease associations, expression, mutations, and clinical significance.

Gene Information Card

Symbol RPE65
Full Name Retinal pigment epithelium-specific 65 kDa protein
Gene Type Protein coding
Chromosomal Location 1p31.3 (GRCh38: chr1:68,428,822-68,449,275, minus strand)
NCBI Gene ID 6121 ncbi.nlm.nih.gov/gene/6121
Ensembl ID ENSG00000116745
UniProt ID Q16518
OMIM ID 180069
HGNC ID 10294
Aliases LCA2, RP20, rd12, p63, mRPE65

Description

RPE65 encodes a 65-kDa protein predominantly expressed in the retinal pigment epithelium (RPE). It functions as an isomerohydrolase in the visual cycle, converting all-trans-retinyl esters to 11-cis-retinol, a critical step for regenerating the visual chromophore 11-cis-retinal. Mutations in RPE65 cause autosomal recessive early-onset severe retinal dystrophy, including Leber congenital amaurosis type 2 (LCA2) and retinitis pigmentosa type 20 (RP20). The gene is also a target for gene therapy (voretigene neparvovec).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Leber congenital amaurosis 2 (LCA2) Loss-of-function mutations in RPE65 disrupt the isomerohydrolase activity, leading to impaired 11-cis-retinal regeneration and photoreceptor degeneration. OMIM #204100; ClinVar; multiple pathogenic variants documented
Retinitis pigmentosa 20 (RP20) Biallelic mutations cause progressive rod-cone dystrophy due to visual cycle failure. OMIM #613794; ClinVar
Early-onset severe retinal dystrophy (EOSRD) RPE65 mutations are a common cause of EOSRD, with variable severity. ClinVar; literature (e.g., den Hollander et al., 2008)

Expression Profile

Tissue Expression
Tissue nTPM level
Retinal pigment epithelium Not available (GTEx lacks RPE) High (specific)
Testis 0.4 Low
Brain (cerebellum) 0.2 Low
Other tissues 0.0-0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
ARPE-19 (RPE cell line) Not available Endogenous expression; used in RPE studies
HeLa 0.0 No expression
HepG2 0.0 No expression
K562 0.0 No expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.11+2T>A (IVS1+2T>A) Splice donor Common in North American LCA patients Splice defect leading to loss of function
p.Arg91Trp (c.271C>T) Missense Found in various populations; pathogenic Reduced enzymatic activity
p.Leu408Pro (c.1223T>C) Missense Reported in LCA Disrupts protein folding/function
p.Tyr368Ter (c.1104C>A) Nonsense Rare Premature truncation, loss of function
p.Glu417Gln (c.1249G>C) Missense Reported in RP Impaired isomerase activity
Mutation functional classification

Loss of Function (LOF)

Most RPE65 mutations are loss-of-function, leading to reduced or absent isomerohydrolase activity, causing retinal dystrophy.

Gain of Function (GOF)

No gain-of-function mutations reported; RPE65 is not known to act as an oncogene.

Dominant Negative (DN)

No dominant-negative mechanism; disease is autosomal recessive.

Pathways

Visual cycle (retinoid metabolism)
Retinol metabolism (KEGG: hsa00830)
Vitamin A metabolism

Protein Summary

RPE65 is a 533-amino acid protein (UniProt Q16518) localized to the endoplasmic reticulum membrane of retinal pigment epithelium cells. It binds all-trans-retinyl esters and catalyzes the conversion to 11-cis-retinol via a ferrous iron-dependent isomerohydrolase mechanism. The protein is essential for vision; its deficiency leads to accumulation of retinyl esters and lack of 11-cis-retinal, causing photoreceptor degeneration. RPE65 is also a target for gene therapy (Luxturna).

Related Products

Product name Cat.No. Species Gene ID
RPE65 Knockout HEK293 Cell Line EDJ-KQ2185 Human 6121 Details Get a Quote
RPE65 Knockout HeLa Cell Line EDJ-KQ54339 Human 6121 Details Get a Quote
RPE65 Knockout A-549 Cell Line EDJ-KQ62835 Human 6121 Details Get a Quote
RPE65 Knockout HCT 116 Cell Line EDJ-KQ71301 Human 6121 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: